REGISTER: Hear how Fulcrum Metals (FMET) is board restructuring to support its strategic focus on Canada. Find out at the focusIR Feb Investor Webinar. Sign up here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Don't want ads? Click here
Sponsored Content
Don't want ads? Click here

Oxford Nanopore buoyed by improved margins and strong sales growth

Mon, 13th Jan 2025 09:34

(Alliance News) - Oxford Nanopore Technologies PLC on Monday said it is on-track for financial breakeven in 2027, as it expects to report better-than-expected margins in 2024 alongside a solid jump in revenue.

The Oxford-based DNA and RNA sequencing specialist said commercial performance accelerated in the second half of calendar 2024, in line with guidance.

Full year performance also was in line with guidance, with revenue estimated around GBP183 million, up 11% on a constant currency basis, or 8% on a reported basis, from GBP169.7 million in 2023.

In response, shares in Oxford Nanopore leapt 16% to 152.19 pence each on Monday morning in London, setting an earlier high of 164.30p. The company has a market value of GBP1.48 billion and last month was promoted to the FTSE 250 index.

Growth was driven by expansion into end-markets outside of Research, such as Applied Industrial, BioPharma and Clinical, Oxford Nanopore said.

The figure includes an around GBP16 million combined headwind from Covid sequencing and the Emirati Genome Program, slightly less than previously expected. Underlying revenue growth at constant currency excluding these headwinds was around 23%, the firm said.

Underlying growth was strongest across the PromethION product range, up around 55% in 2024, primarily driven by increasing customer flow cell utilisation. This helped offset softness in the MinION product range, which declined in the period due to a mix of factors primarily related to product life cycle management, as previously outlined, that continued into the second half.

On a geographical basis the group delivered strong underlying revenue growth in all regions, led by Europe, the Middle East and Africa and Asia-Pacific.

Gross margin for the full year is expected to be slightly above financial 2024 guidance of around 57%.

Oxford Nanopore reiterated medium-term guidance, predicting improving top line momentum and further gross margin expansion. This will help deliver adjusted earnings before interest, tax, depreciation and amortisation breakeven in 2027, the company said.

Oxford Nanopore expects revenue to grow at a compound annual growth rate of more than 30% at constant currency between 2024 and 2207, underpinned by continued penetration in existing markets and expansion into emerging end-market opportunities, in particular across BioPharma, Clinical and Applied Industrial.

Gross margin is expected to continue to improve and exceed 62% by 2027, supported by continued manufacturing efficiencies, increased volume growth and further penetration of new end-markets.

Oxford Nanopore expects to reach adjusted Ebitda breakeven in 2027 and become cash flow positive in 2028.

Chief Executive Officer Gordon Sanghera said he was "pleased" with the performance in 2024. "We are particularly encouraged by the increasing momentum delivered across all regions into the second half of 2024."

This "alongside our growing opportunity pipeline gives us confidence as we enter 2025," Sanghera said.

Looking ahead, Sanghera said "strengthened commercial and operational capabilities combined with a strong balance sheet, position us well to deliver long-term, sustainable, above-market growth."

Oxford Nanopore will announce its results for the twelve months to December 31 on March 4.

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
13 Jan 2025 15:19

London close: Stocks fall, pound weakens further on rising bond yields

(Sharecast News) - London stocks ended Monday in negative territory, pressured by rising bond yields and diminished expectations for near-term interes...

13 Jan 2025 09:03

LONDON MARKET OPEN: FTSE 100 down, Reeves fails to lift mood

(Alliance News) - Stock prices in London opened in the red on Monday, after Friday's US jobs data increased expectations of a pause in rate cuts this ...

13 Jan 2025 07:54

Oxford Nanopore shares jump on margin guidance

(Sharecast News) - Shares in Oxford Nanopore Technologies surged on Monday after the DNA and RNA analysis firm reported an acceleration in momentum to...

13 Jan 2025 07:48

LONDON BRIEFING: Stocks red, China exports surge before Trump tariffs

(Alliance News) - The FTSE 100 was called lower on Monday, after Friday's US jobs data strengthened Federal Reserve hawks' hand and made rate cuts les...

Track Your Investments

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.